0001564590-20-051722 | 10-Q | XBRL Viewer

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2020	Oct. 30, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Entity Registrant Name	ADDUS HOMECARE CORPORATION
Entity Central Index Key	0001468328
Trading Symbol	ADUS
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Address, State or Province	TX
Entity File Number	001-34504
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Frisco
Entity Address, Postal Zip Code	75034
City Area Code	(469)
Local Phone Number	535-8200
Entity Common Stock, Shares Outstanding		15,808,708
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash	$ 170,331	$ 111,714
Accounts receivable, net	118,623	149,680
Prepaid expenses and other current assets	10,426	7,993
Total current assets	299,380	269,387
Property and equipment, net of accumulated depreciation and amortization	19,305	12,156
Other assets
Goodwill	286,552	275,368
Intangibles, net of accumulated amortization	52,873	57,079
Deferred tax assets, net	1,479	1,647
Operating lease assets, net	35,842	21,111
Total other assets	376,746	355,205
Total assets	695,431	636,748
Current liabilities
Accounts payable	17,270	19,641
Accrued payroll	26,315	30,587
Accrued expenses	33,395	22,429
Accrued workers' compensation insurance	14,668	14,143
Current portion of long-term debt	2,095	728
Total current liabilities	93,743	87,528
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs	59,561	59,164
Long-term operating lease liabilities	33,977	14,301
Other long-term liabilities	550	163
Total long-term liabilities	94,088	73,628
Total liabilities	187,831	161,156
Stockholders' equity
Common stock—$.001 par value; 40,000 authorized and 15,801 and 15,617 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	16	15
Additional paid-in capital	366,868	359,545
Retained earnings	140,716	116,032
Total stockholders' equity	507,600	475,592
Total liabilities and stockholders' equity	$ 695,431	$ 636,748

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	15,801,000	15,617,000
Common stock, shares outstanding	15,801,000	15,617,000

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Net service revenues	$ 193,987	$ 168,993	$ 568,779	$ 456,415
Cost of service revenues	137,686	123,817	401,646	334,719
Gross profit	56,301	45,176	167,133	121,696
General and administrative expenses	40,733	35,085	125,470	94,109
Depreciation and amortization	3,045	2,756	8,872	7,365
Total operating expenses	43,778	37,841	134,342	101,474
Operating income from continuing operations	12,523	7,335	32,791	20,222
Interest income	(87)	(786)	(576)	(1,096)
Interest expense	680	866	2,309	2,164
Total interest expense, net	(593)	(80)	(1,733)	(1,068)
Income from continuing operations before income taxes	11,930	7,255	31,058	19,154
Income tax expense	2,811	1,769	6,374	4,080
Net income from continuing operations	9,119	5,486	24,684	15,074
Net loss from discontinued operations		(574)		(574)
Net income	$ 9,119	$ 4,912	$ 24,684	$ 14,500
Basic income per share
Continuing operations	$ 0.58	$ 0.40	$ 1.59	$ 1.14
Discontinued operations		(0.04)		(0.04)
Basic income per share	0.58	0.36	1.59	1.10
Diluted income per share
Continuing operations	0.57	0.39	1.55	1.10
Discontinued operations		(0.04)		(0.04)
Diluted income per share	$ 0.57	$ 0.35	$ 1.55	$ 1.06
Weighted average number of common shares and potential common shares outstanding:
Basic	15,618	13,766	15,573	13,271
Diluted	15,957	14,203	15,934	13,687

Condensed Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2018	$ 268,491	$ 13	$ 177,683	$ 90,795
Balance, shares at Dec. 31, 2018		13,126
Issuance of shares of common stock under restricted stock award agreements, shares		64
Forfeiture of shares of common stock under restricted stock award agreements, shares		(4)
Stock-based compensation	4,186		4,186
Shares issued for exercise of stock options	2,077		2,077
Shares issued for exercise of stock options, shares		73
Shares issued in Public Offering, net of offering costs	172,945	$ 2	172,943
Shares issued in public offering, net of offering costs, shares		2,300
Net income	14,500			14,500
Balance at Sep. 30, 2019	462,199	$ 15	356,889	105,295
Balance, shares at Sep. 30, 2019		15,559
Balance at Jun. 30, 2019	281,507	$ 13	181,111	100,383
Balance, shares at Jun. 30, 2019		13,219
Issuance of shares of common stock under restricted stock award agreements, shares		1
Forfeiture of shares of common stock under restricted stock award agreements, shares		(4)
Stock-based compensation	1,470		1,470
Shares issued for exercise of stock options	1,365		1,365
Shares issued for exercise of stock options, shares		43
Shares issued in Public Offering, net of offering costs	172,945	$ 2	172,943
Shares issued in public offering, net of offering costs, shares		2,300
Net income	4,912			4,912
Balance at Sep. 30, 2019	462,199	$ 15	356,889	105,295
Balance, shares at Sep. 30, 2019		15,559
Balance at Dec. 31, 2019	475,592	$ 15	359,545	116,032
Balance, shares at Dec. 31, 2019		15,617
Issuance of shares of common stock under restricted stock award agreements, shares		81
Forfeiture of shares of common stock under restricted stock award agreements, shares		(6)
Stock-based compensation	3,987		3,987
Shares issued for exercise of stock options	3,337	$ 1	3,336
Shares issued for exercise of stock options, shares		109
Net income	24,684			24,684
Balance at Sep. 30, 2020	507,600	$ 16	366,868	140,716
Balance, shares at Sep. 30, 2020		15,801
Balance at Jun. 30, 2020	494,861	$ 16	363,248	131,597
Balance, shares at Jun. 30, 2020		15,665
Issuance of shares of common stock under restricted stock award agreements, shares		81
Stock-based compensation	1,462		1,462
Shares issued for exercise of stock options	2,158		2,158
Shares issued for exercise of stock options, shares		55
Net income	9,119			9,119
Balance at Sep. 30, 2020	$ 507,600	$ 16	$ 366,868	$ 140,716
Balance, shares at Sep. 30, 2020		15,801

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 24,684	$ 14,500
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisitions:
Depreciation and amortization	8,872	7,365
Deferred income taxes	51	105
Stock-based compensation	3,987	4,186
Amortization of debt issuance costs under the credit facility	554	533
Provision for doubtful accounts	681	168
Loss (gain) of disposal of assets and asset impairment	1,242	(90)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	30,746	(19,957)
Prepaid expenses and other current assets	(2,592)	2,822
Accounts payable	(2,496)	1,856
Accrued expenses and other long-term liabilities	7,570	(3,404)
Net cash provided by operating activities	73,299	8,084
Cash flows from investing activities:
Purchases of property and equipment	(5,893)	(3,077)
Acquisitions of businesses, net of cash acquired	(11,869)	(53,224)
Proceeds from disposal of assets	255
Net cash used in investing activities	(17,507)	(56,301)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs		172,945
Borrowings on revolver — credit facility		23,458
Borrowings on term loan — credit facility		19,600
Payments on term loan — credit facility	(490)	(245)
Payments for debt issuance costs under the credit facility		(361)
Payments on financing lease obligations	(22)	(54)
Cash received from exercise of stock options	3,337	2,077
Net cash provided by financing activities	2,825	217,420
Net change in cash	58,617	169,203
Cash, at beginning of period	111,714	70,406
Cash, at end of period	170,331	239,609
Supplemental disclosures of cash flow information:
Cash paid for interest	1,869	1,594
Cash paid for income taxes	9,119	5,808
Supplemental disclosures of non-cash investing and financing activities:
Leasehold improvements acquired through tenant allowances	$ 4,871	$ 682

Nature of Operations, Consolidation, and Presentation of Financial Statements

9 Months Ended

Sep. 30, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Nature of Operations, Consolidation, and Presentation of Financial Statements

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us” or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care services segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The Company’s payors include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2019 has been derived from the Company’s audited financial statements for the year ended December 31, 2019 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2019 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include revenue recognition, accounts receivable and allowances and goodwill and intangible assets. Actual results could differ from those estimates.

Diluted Net Income Per Common Share

Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company’s outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.

As of September 30, 2020 and 2019, dilutive stock options outstanding were approximately 523,000 and 650,000, respectively, and dilutive restricted stock awards outstanding were approximately 149,000 and 147,000, respectively.

Included in the Company’s calculation of diluted earnings per share for the three and nine months ended September 30, 2020, dilutive stock options outstanding were approximately 301,000 and 303,000, respectively. In addition, dilutive restricted stock awards outstanding were approximately 38,000 and 58,000 for the three and nine months ended September 30, 2020, respectively.

Included in the Company’s calculation of diluted earnings per share for the three and nine months ended September 30, 2019, were approximately 359,000 and 335,000 dilutive stock options outstanding, respectively. In addition, dilutive restricted stock awards outstanding were approximately 78,000 and 81,000 for the three and nine months ended September 30, 2019, respectively.

Recently Adopted Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. We have reviewed our provision for doubtful accounts process as required by ASU 2016-13. Management estimates allowances on accounts receivable based upon historical experience and other factors, including an aging of accounts receivable, evaluation of expected adjustments, past adjustments and collection experience in relation to amounts billed, current contract and reimbursement terms, shifts in payors and other current relevant information. The Company recorded a provision for doubtful accounts of $0.2 million and $0.7 million for the three and nine months ended September 30, 2020, respectively. Allowance for doubtful accounts was $0.8 million and $1.0 million as of September 30, 2020 and December 31, 2019, respectively. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e., measure the charge based on the current Step 1). Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification (“ASC”) 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

Recently Issued Accounting Pronouncements

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 intends to simplify various aspects related to accounting for income taxes and removes certain exceptions to the general guidance in ASC 740. In addition, the ASU clarifies and amends existing guidance to improve consistent application of its requirements. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. Adoption of the new standard is not expected to have an impact on our results of operations or liquidity.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, and other transactions subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. Therefore, it will be in effect for a limited time through December 31, 2022. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance.

Revision of Previously Issued Financial Statements

9 Months Ended

Sep. 30, 2020

Accounting Changes And Error Corrections [Abstract]

Revision of Previously Issued Financial Statements

3. Revision of Previously Issued Financial Statements

In connection with management finalizing their financial reporting close process for the year ended December 31, 2019, management identified certain immaterial errors impacting the current period and previous periods dating back to periods prior to 2017, including interim periods within those years. Specifically, management determined there were certain errors in the information utilized to accurately estimate the implicit price concessions necessary to reduce net service revenues to the amount expected to be collected. Accordingly, management determined that our accounts receivable allowance was understated. The correction reflects the impact on the Company’s income tax provision and related accounts as a result of correcting for the error as discussed above. Additionally, the Company identified and corrected other immaterial unrelated income tax items impacting deferred tax assets and other immaterial items.

Management evaluated the impact of the errors on all previously issued financial statements and concluded such previously issued financial statements were not materially misstated; however, to reflect such corrections in the quarter ended December 31, 2019 financial statements would materially misstate the 2019 fiscal year. Accordingly, management revised previously issued financial statements to correct for the impact of the errors. The Company’s consolidated financial statements have been revised from the amounts previously reported to correct these immaterial errors as shown in the tables below and are reflected throughout the financial statements and related notes, as applicable.

The Consolidated Statements of Income has been revised to reflect the correction for the three and nine months ended September 30, 2019 as follows (amounts in thousands, except per share data):

	For the Three Months Ended September 30,							For the Nine Months Ended September 30,
	2019							2019
	As							As
	Previously					As		Previously					As
	Reported		Revision			Revised		Reported		Revision			Revised
Net service revenues	$	169,803	$	(810	)	$	168,993	$	458,749	$	(2,334	)	$	456,415
Gross profit		45,986		(810	)		45,176		124,030		(2,334	)		121,696
General and administrative expenses		35,950		(865	)		35,085		95,429		(1,320	)		94,109
Total operating expenses		38,706		(865	)		37,841		102,794		(1,320	)		101,474
Operating income from continuing operations		7,280		55			7,335		21,236		(1,014	)		20,222
Income from continuing operations before income taxes		7,200		55			7,255		20,168		(1,014	)		19,154
Income tax expense		1,759		10			1,769		4,347		(267	)		4,080
Net income from continuing operations		5,441		45			5,486		15,821		(747	)		15,074
Net income	$	4,867	$	45		$	4,912	$	15,247	$	(747	)	$	14,500
Basic income per share	$	0.36	$	—		$	0.36	$	1.15	$	(0.05	)	$	1.10
Diluted income per share	$	0.34	$	0.01		$	0.35	$	1.12	$	(0.06	)	$	1.06

Additionally, the Consolidated Statement of Cash Flows has been revised to reflect the correction for the nine months ended September 30, 2019 as follows:

	For the Nine Months Ended September 30, (Amounts in Thousands)
	2019
	As
	Previously						As
	Reported			Revision			Revised
Net income	$	15,247		$	(747	)	$	14,500
Deferred income taxes		372			(267	)		105
Accounts receivable		(22,291	)		2,334			(19,957	)
Accrued expenses and other long-term liabilities		(2,084	)		(1,320	)		(3,404	)
Net cash provided by operating activities	$	8,084		$	—		$	8,084

Leases

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Leases

4. Leases

We have historically entered into operating leases for local branches, our corporate headquarters and certain equipment. The Company’s current leases have expiration dates through 2031. Certain of our arrangements have free rent periods and/or escalating rent payment provisions. We recognize rent expense on a straight-line basis over the lease term. Certain of the Company’s leases include termination options and renewal options for periods ranging from one to five years. Because we are not reasonably certain to exercise these renewal options, the options generally are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments.

When available, we use the rate implicit in the lease to discount lease payments to present value; however, most of our leases do not provide a readily determinable implicit rate. Therefore, we must estimate our incremental borrowing rate to discount the lease payments based on information available at lease commencement.

Amounts reported in the Company’s Unaudited Condensed Consolidated Balance Sheets as of September 30, 2020 and Audited Consolidated Balance Sheets as of December 31, 2019 for our operating leases were as follows:

	September 30, 2020		December 31, 2019
	(Amounts in Thousands)
Operating lease assets, net	$	35,842	$	21,111

Short-term operating lease liabilities (in accrued expenses)		8,057		7,234
Long-term operating lease liabilities		33,977		14,301
Total operating lease liabilities	$	42,034	$	21,535

The Company signed an eleven-year lease agreement to expand its Frisco corporate headquarters from 31,000 square feet to approximately 75,000 square feet which resulted in an increase in the operating lease asset, net, and operating lease liability by approximately $17.3 million and $22.2 million, respectively, during the three and nine months ended September 30, 2020.

Lease Costs

Components of lease cost were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	For the Three Months Ended September 30, (Amounts in Thousands)				For the Nine Months Ended September 30, (Amounts in Thousands)
	2020		2019		2020		2019
Operating lease costs	$	2,285	$	1,897	$	6,524	$	5,101
Short-term lease costs		147		222		575		382
Total lease cost	$	2,432	$	2,119	$	7,099	$	5,483

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

	September 30, 2020			December 31, 2019
Operating leases:
Weighted average remaining lease term		7.24			3.42
Weighted average discount rate		4.33	%		5.14	%

Maturity of Lease Liabilities

A summary of our remaining operating lease payments as of September 30, 2020 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended September 30,
2021	$	9,176
2022		8,704
2023		6,366
2024		4,704
2025		3,549
Thereafter		16,783
Total future minimum rental commitments		49,282
Less: Imputed interest		(7,248	)
Total lease liabilities	$	42,034

Supplemental cash flows information

	For the Nine Months Ended September 30, (Amounts in Thousands)
	2020		2019
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	6,472	$	5,393

Right-of-use assets, net obtained in exchange for lease obligations:
Operating leases		21,399		5,536

Acquisitions

9 Months Ended

Sep. 30, 2020

Business Combinations [Abstract]

Acquisitions

5. Acquisitions

The Company’s acquisitions have been accounted for in accordance with ASC Topic 805, Business Combinations, and the resulting goodwill and other intangible assets were accounted for under ASC Topic 350, Goodwill and Other Intangible Assets. Under business combination accounting, the assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The results of each business acquisition are included on the Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.

Management’s assessment of qualitative factors affecting goodwill for each acquisition includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations and the payor profile in the markets.

A Plus Health Care

On July 1, 2020, we completed the acquisition of A Plus Health Care, Inc. (“A Plus”). The purchase price was approximately $12.2 million plus the amount of excess cash held by A Plus at closing (approximately $2.8 million). The purchase of A Plus was funded with the Company’s available cash. With the purchase of A Plus, the Company expanded its personal care services in the state of Montana. The related acquisition costs were $0.3 million for the three and nine months ended September 30, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	11,252
Identifiable intangible assets		1,523
Cash		2,819
Accounts receivable		1,075
Operating lease assets, net		180
Other assets		23
Accounts payable		(18	)
Accrued expenses		(202	)
Accrued payroll		(303	)
Current portion of long-term debt		(577	)
Long-term debt		(1,145	)
Long-term operating lease liabilities		(100	)
Total purchase price	$	14,527

Identifiable intangible assets acquired included $1.4 million in trade names with an estimated useful life of fifteen years. The preliminary estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The A Plus acquisition accounted for $2.6 million of net service revenues and $0.5 million of operating income for the three and nine months ended September 30, 2020, respectively.

Hospice Partners

On October 1, 2019, the Company completed the acquisition of the assets of Hospice Partners of America, LLC (“Hospice Partners”). The purchase price was approximately $135.6 million. The purchase of Hospice Partners was funded through a portion of the net proceeds of our public offering of an aggregate 2,300,000 shares of common stock, par value $0.001 per share, including 300,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares at a public offering price of $79.50 per share, which the Company completed on September 9, 2019 (the “Public Offering”). With the purchase of Hospice Partners, we expanded our hospice operations through 21 locations in Idaho, Kansas, Missouri, Oregon, Texas and Virginia. The related integration costs were $1.5 million for the nine months ended September 30, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	111,674
Identifiable intangible assets		18,090
Cash		5,489
Property and equipment		164
Accounts receivable		6,411
Operating lease assets, net		2,425
Other assets		702
Accounts payable		(1,737	)
Accrued expenses		(3,503	)
Accrued payroll		(1,110	)
Deferred tax liability		(1,422	)
Long-term operating lease liabilities		(1,615	)
Total purchase price	$	135,568

Identifiable intangible assets acquired consist of $9.5 million in trade names with estimated useful lives of fifteen years, $2.5 million in non-competition agreements with estimated useful lives of three to five years and $6.1 million of indefinite lived state licenses. The estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Hospice Partners acquisition accounted for $13.0 million and $40.3 million of net service revenues and $3.5 million and $9.5 million of operating income for the three and nine months ended September 30, 2020, respectively.

Alliance Home Health Care

On August 1, 2019, the Company completed the acquisition of all of the assets of Alliance Home Health Care (“Alliance”). The purchase price was approximately $23.5 million. The purchase of Alliance was funded through the Company’s revolving credit facility and available cash. With the purchase of Alliance, the Company expanded its personal care, home health and hospice operations in the state of New Mexico. The related acquisition costs were $0.3 million for the three and nine months ended September 30, 2019. The related integration costs were $0.2 million for the nine months ended September 30, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	17,062
Identifiable intangible assets		5,422
Cash		177
Accounts receivable		1,754
Accounts payable		(316	)
Other liabilities		(641	)
Total purchase price	$	23,458

Identifiable intangible assets acquired consist of $1.1 million in state licenses, subject to amortization, with an estimated useful life of ten years and $4.3 million of indefinite lived state licenses. The estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Alliance acquisition accounted for $3.3 million and $3.4 million of net service revenues for the three months ended September 30, 2020 and 2019, respectively, and $12.0 million and $3.4 million for the nine months ended September 30, 2020 and 2019, respectively. Operating income accounted for $0.7 million and $0.8 million for the three months ended September 30, 2020 and 2019, respectively, and $2.7 million and $0.8 million for the nine months ended September 30, 2020 and 2019, respectively.

VIP Health Care Services

On June 1, 2019, the Company completed the acquisition of all of the assets of VIP Health Care Services (“VIP”). The purchase price was approximately $29.9 million. The purchase of VIP was funded through a combination of the Company’s delayed draw term loan portion of its credit facility and available cash. With the purchase of VIP, the Company expanded its personal care operations in the state of New York and into the New York City metropolitan area. The related acquisition costs were $0.3 million for the nine months ended September 30, 2019. The related integration costs were $0.2 million for the nine months ended September 30, 2020, and $0.2 million and $0.3 million for the three and nine months ended September 30, 2019, respectively. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	11,936
Identifiable intangible assets		15,370
Cash		130
Accounts receivable		4,730
Operating lease assets, net		2,278
Other assets		30
Property and equipment		27
Accounts payable		(540	)
Accrued expenses		(770	)
Accrued payroll		(1,742	)
Long-term operating lease liabilities		(1,531	)
Total purchase price	$	29,918

Identifiable intangible assets acquired consist of $10.7 million in state licenses, subject to amortization, and $4.7 million in customer relationships, with estimated useful lives of six and eight years, respectively. The estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The VIP acquisition accounted for $9.7 million and $13.2 million of net service revenues for the three months ended September 30, 2020 and 2019, respectively, and $30.5 million and $17.6 million for the nine months ended September 30, 2020 and 2019, respectively, and $0.4 million of operating loss for each of the three months ended September 30, 2020 and 2019, and $1.1 million and $0.1 million of operating loss for the nine months ended September 30, 2020 and 2019, respectively.

The following table contains unaudited pro forma condensed consolidated income statement information of the Company for the three and nine months ended September 30, 2020 and 2019 as if each of the acquisitions of Hospice Partners, Alliance, VIP and A Plus closed on January 1, 2019.

	For the Three Months Ended September 30, (Amounts in Thousands)				For the Nine Months Ended September 30, (Amounts in Thousands)
	2020		2019		2020		2019
Net service revenues	$	193,987	$	187,846	$	573,917	$	541,646
Operating income from continuing operations		12,269		9,291		32,136		26,328
Net income from continuing operations		9,458		6,922		25,663		20,518
Net income per common share from continuing operations
Basic income per share	$	0.61	$	0.50	$	1.65	$	1.55

The pro forma disclosures in the table above include adjustments for amortization of intangible assets, tax expense and acquisition costs to reflect results that are more representative of the combined results of the transactions as if Hospice Partners, Alliance, VIP and A Plus had been acquired effective January 1, 2019. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operations that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information. The unaudited pro forma financial information does not reflect the impact of future events that may occur after the acquisition, such as anticipated cost savings from operating synergies.

Goodwill and Intangible Assets

9 Months Ended

Sep. 30, 2020

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

6. Goodwill and Intangible Assets

A summary of the goodwill activity for the nine months ended September 30, 2020 is provided below:

	Goodwill
	Personal Care		Hospice			Home Health			Total
	(Amounts in Thousands)
Goodwill as of December 31, 2019	$	126,577	$	146,983		$	1,808		$	275,368
Additions for acquisition		11,252		—			—			11,252
Divestiture		—		(1,167	)		—			(1,167	)
Adjustments to previously recorded goodwill		1,438		(322	)		(17	)		1,099
Goodwill as of September 30, 2020	$	139,267	$	145,494		$	1,791		$	286,552

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names, trademarks and non-competition agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from three to twenty-five years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years. Goodwill and certain state licenses are not amortized pursuant to ASC Topic 350.

The Company recognized goodwill in the personal care segment of $11.3 million related to the acquisition of A Plus during the nine months ended September 30, 2020. For the three and nine months ended September 30, 2020, adjustments to previously recorded goodwill are primarily adjustments to accounts receivable based on the final valuations for the acquisitions of Hospice Partners, Alliance and VIP. During the nine months ended September 30, 2020, the Company divested certain branches and their related net assets including $1.2 million of related goodwill. The Company recognized $0.3 million loss on the disposition, reflected as a reduction in general and administrative expense for the nine months ended September 30, 2020.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following as of September 30, 2020:

	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)
Intangible assets with indefinite lives		—			—			—			13,296			13,296
Intangible assets subject to amortization:
Gross carrying amount		48,028			31,946			4,655			12,164			96,793
Accumulated amortization		(37,263	)		(14,671	)		(2,716	)		(2,566	)		(57,216	)
Intangible assets subject to amortization, net		10,765			17,275			1,939			9,598			39,577
Total intangible assets at September 30, 2020	$	10,765		$	17,275		$	1,939		$	22,894		$	52,873

During the nine months ended September 30, 2020, the Company acquired a trade name of $1.4 million related to the acquisition of A Plus. Amortization expense related to identifiable intangible assets amounted to $1.7 million and $5.3 million for the three and nine months ended September 30, 2020, respectively, and $1.8 million and $4.4 million for the three and nine months ended September 30, 2019, respectively. The weighted average remaining lives of identifiable intangible assets as of September 30, 2020 is 8.7 years.

Details of Certain Balance Sheet Accounts

9 Months Ended

Sep. 30, 2020

Details Of Certain Balance Sheet Accounts [Abstract]

Details of Certain Balance Sheet Accounts

7. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

	September 30, 2020		December 31, 2019
	(Amounts in Thousands)
Income tax receivable	$	2,533	$	—
Workers’ compensation insurance receivable		2,186		1,989
Prepaid workers' compensation and liability insurance		1,792		2,040
Health insurance receivable		426		1,567
Other		3,489		2,397
Total prepaid expenses and other current assets	$	10,426	$	7,993

Accrued expenses consisted of the following:

	September 30, 2020		December 31, 2019
	(Amounts in Thousands)
Accrued payroll taxes ⁽¹⁾	$	8,448	$	1,843
Current portion of operating lease liabilities		8,057		7,234
Accrued health insurance		4,413		4,140
Accrued professional fees		3,135		2,517
Other		9,342		6,695
Total accrued expenses	$	33,395	$	22,429

(1)	The Company deferred $7.1 million of payroll taxes in connection to a provision included in the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), see Note 10 to the Notes to Consolidated Financial Statements for additional information.

Long-Term Debt

9 Months Ended

Sep. 30, 2020

Long Term Debt [Abstract]

Long-Term Debt

8. Long-Term Debt

Long-term debt consisted of the following:

	September 30, 2020			December 31, 2019
	(Amounts in Thousands)
Revolving loan under the credit facility	$	43,458		$	43,458
Term loan under the credit facility		18,375			18,865
Other debt		1,722			—
Financing leases		—			21
Less unamortized issuance costs		(1,899	)		(2,452	)
Total	$	61,656		$	59,892
Less current maturities		(2,095	)		(728	)
Long-term debt	$	59,561		$	59,164

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, dated as of October 31, 2018, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders (as amended by the Amendment (as hereinafter defined), the “Credit Agreement”), which amended and restated the Company’s existing credit agreement. This credit facility totaled $269.6 million, inclusive of a $250.0 million revolving loan and a $19.6 million delayed draw term loan, and is evidenced by the Credit Agreement. This credit facility amended and restated the Company’s existing senior secured credit facility totaling $250.0 million. As used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement. The maturity of this credit facility is May 8, 2023. Interest on the Company’s credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than 0.00%) plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the offered rate per annum for similar dollar deposits for the applicable interest period that appears on Reuters Screen LIBOR01 Page (not to be less than zero). Swing loans may not be LIBOR loans. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters. In connection with this amended and restated credit facility, the Company incurred approximately $0.9 million of debt issuance costs.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this amended and restated credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets.

On September 12, 2019, the Company entered into a First Amendment (the “Amendment”) to its Credit Agreement. The Amendment increased the Company’s credit facility by $50.0 million in incremental revolving loans, for an aggregate $300.0 million in revolving loans. The Amendment provides that future incremental loans may be for term loans or an increase to the revolving loan commitments. The Amendment further provides that the proceeds of the incremental revolving loan commitments may be used for, among other things, general corporate purposes. In connection with the modification of this Amendment, the Company incurred approximately $0.4 million of debt issuance costs.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the amended and restated credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement thresholds), restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business. As of September 30, 2020, the Company was in compliance with all financial covenants under the Credit Agreement.

During the nine months ended September 30, 2020, the Company had no draws under its credit facility.

As of September 30, 2020, the Company had a total of $43.4 million of revolving loans, with an interest rate of 1.89% and $18.4 million of term loans, with an interest rate of 1.89%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $9.3 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $219.0 million available for borrowing under its credit facility.

As of December 31, 2019, the Company had a total of $43.4 million of revolving loans, with an interest rate of 3.44%, and $18.9 million of term loans, with an interest rate of 3.45%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $10.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $191.4 million available for borrowing under its credit facility.

Income Taxes

9 Months Ended

Sep. 30, 2020

Income Tax Disclosure [Abstract]

Income Taxes

9. Income Taxes

The effective income tax rates are 23.6% and 24.4% for the three months ended September 30, 2020 and 2019, respectively. For the three months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes and non-deductible compensation, partially offset by an excess tax benefit and the use of federal employment tax credits.

The effective income tax rates are 20.5% and 21.3% for the nine months ended September 30, 2020 and 2019, respectively. For the nine months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of an excess tax benefit and the use of federal employment tax credits partially offset by state taxes and non-deductible compensation. The excess tax benefit is a discrete item, related to the vesting of equity shares, which requires the Company to recognize the benefit fully in the period. An excess tax benefit results if the Company’s income tax deduction exceeds the cumulative costs of the award recognized on the Unaudited Condensed Consolidated Statements of Income.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

Commitments and Contingencies

9 Months Ended

Sep. 30, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

10. Commitments and Contingencies

Legal Proceedings

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

Government Actions to Mitigate COVID-19’s Impact

On January 31, 2020, the Secretary of the U.S. Department of Health and Human Services (“HHS”) declared a national public health emergency due to a novel coronavirus. In March 2020, the World Health Organization declared the outbreak of COVID-19, a disease caused by this novel coronavirus, a pandemic. This disease has spread throughout the United States and other parts of the world, and COVID-19 cases have recently been increasing in the United States and Europe. It is impossible to predict the effect and ultimate impact of the COVID-19 pandemic as the situation continues to rapidly evolve.

In recognition of the significant threat to the liquidity of financial markets posed by the COVID-19 pandemic, the Federal Reserve and Congress have taken dramatic actions to provide liquidity to businesses and the banking system in the United States. For example, on March 27, 2020, the President signed into law the CARES Act, a sweeping stimulus bill intended to bolster the U.S. economy. On April 24, 2020, the Paycheck Protection Program and Health Care Enhancement Act (“PPPHCE Act”) was enacted, an expansion of the CARES Act. Together, the CARES Act and the PPPHCE Act authorize $175 billion in funding to be distributed to health care providers through the Relief Fund. This funding is intended to support healthcare providers by reimbursing them for healthcare-related expenses or lost revenues attributable to COVID-19. In addition to relief funding, the CARES Act includes temporary changes to Medicare and Medicaid payment rules and relief from certain accounting provisions.

In April 2020, the Company received grants in an aggregate principal amount of $6.9 million, for which it did not apply, from the Relief Fund as part of the automatic general distributions by HHS. The Company returned these funds in June 2020. The CARES Act includes provisions relating to refundable payroll tax credits, deferral of the employer portion of certain payroll taxes, net operating loss carrybacks, and other areas. The payroll tax deferral requires that the deferred payroll taxes be paid over two years, with half of the amount required to be paid by December 31, 2021 and the other half by December 31, 2022. The Company elected to defer payroll taxes during the quarter ended June 30, 2020 and ceased the deferral election effective June 30, 2020. The Company deferred $7.1 million of payroll taxes, which are included in accrued expenses in the Company’s Unaudited Condensed Consolidated Balance Sheets at September 30, 2020.

Segment Information

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Segment Information

11. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three distinct but related business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy.

The tables below set forth information about the Company’s reportable segments for the three and nine months ended September 30, 2020 and 2019 along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. Segment assets are not reviewed by the Company’s chief operating decision maker function and therefore are not disclosed below.

Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

	For the Three Months Ended September 30, 2020
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	165,916	$	23,986	$	4,085	$	193,987
Cost of services revenues		124,493		10,508		2,685		137,686
Gross profit		41,423		13,478		1,400		56,301
General and administrative expenses		14,837		5,904		925		21,666
Segment operating income	$	26,586	$	7,574	$	475	$	34,635

	For the Three Months Ended September 30, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	153,753	$	10,874	$	4,366	$	168,993
Cost of services revenues		115,504		5,495		2,818		123,817
Gross profit		38,249		5,379		1,548		45,176
General and administrative expenses		14,737		1,824		844		17,405
Segment operating income	$	23,512	$	3,555	$	704	$	27,771

	For the Three Months Ended September 30,
	2020			2019
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	34,635		$	27,771

Items not allocated at segment level:
Other general and administrative expenses		19,067			17,680
Depreciation and amortization		3,045			2,756
Interest income		(87	)		(786	)
Interest expense		680			866
Income before income taxes	$	11,930		$	7,255

	For the Nine Months Ended September 30, 2020
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	482,849	$	73,723	$	12,207	$	568,779
Cost of services revenues		359,344		33,749		8,553		401,646
Gross profit		123,505		39,974		3,654		167,133
General and administrative expenses		45,042		18,658		2,831		66,531
Segment operating income	$	78,463	$	21,316	$	823	$	100,602

	For the Nine Months Ended September 30, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	419,124	$	27,228	$	10,063	$	456,415
Cost of services revenues		314,329		13,587		6,803		334,719
Gross profit		104,795		13,641		3,260		121,696
General and administrative expenses		40,053		4,962		2,187		47,202
Segment operating income	$	64,742	$	8,679	$	1,073	$	74,494

	For the Nine Months Ended September 30,
	2020			2019
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	100,602		$	74,494

Items not allocated at segment level:
Other general and administrative expenses		58,939			46,907
Depreciation and amortization		8,872			7,365
Interest income		(576	)		(1,096	)
Interest expense		2,309			2,164
Income before income taxes	$	31,058		$	19,154

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Significant Payors

9 Months Ended

Sep. 30, 2020

Significant Payors [Abstract]

Significant Payors

12. Significant Payors

For the three and nine months ended September 30, 2020 and 2019, the Company’s revenue by payor type was as follows:

	Personal Care
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	85,344		51.5	%	$	75,176		48.9	%	$	242,751		50.3	%	$	221,450		52.8	%
Managed care organizations		71,700		43.2			68,438		44.5			213,087		44.1			170,004		40.6
Private pay		5,193		3.1			5,720		3.7			15,449		3.2			15,912		3.8
Commercial insurance		2,498		1.5			2,683		1.8			7,468		1.5			6,569		1.6
Other		1,181		0.7			1,736		1.1			4,094		0.9			5,189		1.2	%
Total personal care segment net service revenues	$	165,916		100.0	%	$	153,753		100.0	%	$	482,849		100.0	%	$	419,124		100.0

	Hospice
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	22,404		93.4	%	$	10,045		92.4	%	$	68,372		92.8	%	$	25,243		92.7	%
Managed care organizations		1,130		4.7			584		5.4			3,710		5.0			1,419		5.2
Other		452		1.9			245		2.2			1,641		2.2			566		2.1
Total hospice segment net service revenues	$	23,986		100.0	%	$	10,874		100.0	%	$	73,723		100.0	%	$	27,228		100.0	%

	Home Health
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	3,188		78.0	%	$	3,338		76.5	%	$	9,667		79.2	%	$	7,948		79.0	%
Managed care organizations		829		20.3			959		22.0			2,325		19.0			1,872		18.6
Other		68		1.7			69		1.5			215		1.8			243		2.4
Total home health segment net service revenues	$	4,085		100.0	%	$	4,366		100.0	%	$	12,207		100.0	%	$	10,063		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New York and New Mexico. The percentages of segment revenue for each of these significant states for the three and nine months ended September 30, 2020 and 2019 were as follows:

	Personal Care
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	74,448		44.9	%	$	61,633		40.1	%	$	215,047		44.6	%	$	178,449		42.5	%
New York		28,381		17.1			34,730		22.6			87,463		18.1			75,330		18.0
New Mexico		21,878		13.2			19,559		12.7			64,402		13.3			54,701		13.1
All other states		41,209		24.8			37,831		24.6			115,937		24.0			110,644		26.4
Total personal care segment net service revenues	$	165,916		100.0	%	$	153,753		100.0	%	$	482,849		100.0	%	$	419,124		100.0	%

	Hospice
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	10,979		45.8	%	$	10,874		100.0	%	$	33,431		45.3	%	$	27,228		100.0	%
All other states		13,007		54.2			—		—			40,292		54.7			—		—
Total hospice segment net service revenues	$	23,986		100.0	%	$	10,874		100.0	%	$	73,723		100.0	%	$	27,228		100.0	%

	Home Health
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	4,085		100.0	%	$	4,366		100.0	%	$	12,207		100.0	%	$	10,063		100.0	%
Total home health segment net service revenues	$	4,085		100.0	%	$	4,366		100.0	%	$	12,207		100.0	%	$	10,063		100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state and local governmental agencies. We derive a significant amount of our net service revenues in Illinois, which represented 38.5%, and 36.4% of our net service revenues for the three months ended September 30, 2020, and 2019, respectively and accounted for 37.8% and 39.1% of our net service revenues for the nine months ended September 30, 2020 and 2019, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 22.9% and 22.1% of the Company’s net service revenues for the three months ended September 30, 2020 and 2019, respectively, and accounted for 23.1% and 26.0% of the Company’s net service revenues for the nine months ended September 30, 2020 and 2019, respectively.

The related receivables due from the Illinois Department on Aging represented 18.5% and 25.1% of the Company’s net accounts receivable at September 30, 2020 and December 31, 2019, respectively.

Subsequent Events

9 Months Ended

Sep. 30, 2020

Subsequent Events [Abstract]

Subsequent Events

13. Subsequent Events

On November 1, 2020, we completed the acquisition of County Homemakers Incorporated (“County Homemakers”) for approximately $14.6 million, with funding provided by cash on hand. With the purchase of County Homemakers, we expanded our personal care services in the state of Pennsylvania. The Company is currently assessing the fair value of identifiable net assets acquired.

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2019 has been derived from the Company’s audited financial statements for the year ended December 31, 2019 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2019 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
Principles of Consolidation	Principles of Consolidation These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Estimates	Estimates The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include revenue recognition, accounts receivable and allowances and goodwill and intangible assets. Actual results could differ from those estimates.
Diluted Net Income Per Common Share	Diluted Net Income Per Common Share Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company’s outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards. As of September 30, 2020 and 2019, dilutive stock options outstanding were approximately 523,000 and 650,000, respectively, and dilutive restricted stock awards outstanding were approximately 149,000 and 147,000, respectively. Included in the Company’s calculation of diluted earnings per share for the three and nine months ended September 30, 2020, dilutive stock options outstanding were approximately 301,000 and 303,000, respectively. In addition, dilutive restricted stock awards outstanding were approximately 38,000 and 58,000 for the three and nine months ended September 30, 2020, respectively. Included in the Company’s calculation of diluted earnings per share for the three and nine months ended September 30, 2019, were approximately 359,000 and 335,000 dilutive stock options outstanding, respectively. In addition, dilutive restricted stock awards outstanding were approximately 78,000 and 81,000 for the three and nine months ended September 30, 2019, respectively.
Recently Issued and Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. We have reviewed our provision for doubtful accounts process as required by ASU 2016-13. Management estimates allowances on accounts receivable based upon historical experience and other factors, including an aging of accounts receivable, evaluation of expected adjustments, past adjustments and collection experience in relation to amounts billed, current contract and reimbursement terms, shifts in payors and other current relevant information. The Company recorded a provision for doubtful accounts of $0.2 million and $0.7 million for the three and nine months ended September 30, 2020, respectively. Allowance for doubtful accounts was $0.8 million and $1.0 million as of September 30, 2020 and December 31, 2019, respectively. Adoption of the new standard did not have a significant impact on our results of operations or liquidity. In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e., measure the charge based on the current Step 1). Adoption of the new standard did not have a significant impact on our results of operations or liquidity. In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification (“ASC”) 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. Adoption of the new standard did not have a significant impact on our results of operations or liquidity. Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 intends to simplify various aspects related to accounting for income taxes and removes certain exceptions to the general guidance in ASC 740. In addition, the ASU clarifies and amends existing guidance to improve consistent application of its requirements. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. Adoption of the new standard is not expected to have an impact on our results of operations or liquidity. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, and other transactions subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. Therefore, it will be in effect for a limited time through December 31, 2022. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance.

Revision of Previously Issued Financial Statements (Tables)

9 Months Ended

Sep. 30, 2020

Accounting Changes And Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

The Consolidated Statements of Income has been revised to reflect the correction for the three and nine months ended September 30, 2019 as follows (amounts in thousands, except per share data):

	For the Three Months Ended September 30,							For the Nine Months Ended September 30,
	2019							2019
	As							As
	Previously					As		Previously					As
	Reported		Revision			Revised		Reported		Revision			Revised
Net service revenues	$	169,803	$	(810	)	$	168,993	$	458,749	$	(2,334	)	$	456,415
Gross profit		45,986		(810	)		45,176		124,030		(2,334	)		121,696
General and administrative expenses		35,950		(865	)		35,085		95,429		(1,320	)		94,109
Total operating expenses		38,706		(865	)		37,841		102,794		(1,320	)		101,474
Operating income from continuing operations		7,280		55			7,335		21,236		(1,014	)		20,222
Income from continuing operations before income taxes		7,200		55			7,255		20,168		(1,014	)		19,154
Income tax expense		1,759		10			1,769		4,347		(267	)		4,080
Net income from continuing operations		5,441		45			5,486		15,821		(747	)		15,074
Net income	$	4,867	$	45		$	4,912	$	15,247	$	(747	)	$	14,500
Basic income per share	$	0.36	$	—		$	0.36	$	1.15	$	(0.05	)	$	1.10
Diluted income per share	$	0.34	$	0.01		$	0.35	$	1.12	$	(0.06	)	$	1.06

Additionally, the Consolidated Statement of Cash Flows has been revised to reflect the correction for the nine months ended September 30, 2019 as follows:

	For the Nine Months Ended September 30, (Amounts in Thousands)
	2019
	As
	Previously						As
	Reported			Revision			Revised
Net income	$	15,247		$	(747	)	$	14,500
Deferred income taxes		372			(267	)		105
Accounts receivable		(22,291	)		2,334			(19,957	)
Accrued expenses and other long-term liabilities		(2,084	)		(1,320	)		(3,404	)
Net cash provided by operating activities	$	8,084		$	—		$	8,084

Leases (Tables)

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Amounts Reported in Unaudited and Audited Condensed Consolidated Balance Sheets for Operating Leases

	September 30, 2020		December 31, 2019
	(Amounts in Thousands)
Operating lease assets, net	$	35,842	$	21,111

Short-term operating lease liabilities (in accrued expenses)		8,057		7,234
Long-term operating lease liabilities		33,977		14,301
Total operating lease liabilities	$	42,034	$	21,535

Components of Lease Cost Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income

Components of lease cost were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	For the Three Months Ended September 30, (Amounts in Thousands)				For the Nine Months Ended September 30, (Amounts in Thousands)
	2020		2019		2020		2019
Operating lease costs	$	2,285	$	1,897	$	6,524	$	5,101
Short-term lease costs		147		222		575		382
Total lease cost	$	2,432	$	2,119	$	7,099	$	5,483

Schedule of Weighted Average Remaining Lease Terms and Discount Rates

Weighted average remaining lease terms and discount rates were as follows:

	September 30, 2020			December 31, 2019
Operating leases:
Weighted average remaining lease term		7.24			3.42
Weighted average discount rate		4.33	%		5.14	%

Summary of Remaining Operating Lease Payments

A summary of our remaining operating lease payments as of September 30, 2020 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended September 30,
2021	$	9,176
2022		8,704
2023		6,366
2024		4,704
2025		3,549
Thereafter		16,783
Total future minimum rental commitments		49,282
Less: Imputed interest		(7,248	)
Total lease liabilities	$	42,034

Supplemental Cash Flows Information

	For the Nine Months Ended September 30, (Amounts in Thousands)
	2020		2019
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	6,472	$	5,393

Right-of-use assets, net obtained in exchange for lease obligations:
Operating leases		21,399		5,536

Acquisitions (Tables)

9 Months Ended

Sep. 30, 2020

Business Acquisition [Line Items]

Unaudited Pro Forma Condensed Consolidated Income Statement Information

	For the Three Months Ended September 30, (Amounts in Thousands)				For the Nine Months Ended September 30, (Amounts in Thousands)
	2020		2019		2020		2019
Net service revenues	$	193,987	$	187,846	$	573,917	$	541,646
Operating income from continuing operations		12,269		9,291		32,136		26,328
Net income from continuing operations		9,458		6,922		25,663		20,518
Net income per common share from continuing operations
Basic income per share	$	0.61	$	0.50	$	1.65	$	1.55

A Plus Health Care, Inc [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	11,252
Identifiable intangible assets		1,523
Cash		2,819
Accounts receivable		1,075
Operating lease assets, net		180
Other assets		23
Accounts payable		(18	)
Accrued expenses		(202	)
Accrued payroll		(303	)
Current portion of long-term debt		(577	)
Long-term debt		(1,145	)
Long-term operating lease liabilities		(100	)
Total purchase price	$	14,527

Hospice Partners [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	111,674
Identifiable intangible assets		18,090
Cash		5,489
Property and equipment		164
Accounts receivable		6,411
Operating lease assets, net		2,425
Other assets		702
Accounts payable		(1,737	)
Accrued expenses		(3,503	)
Accrued payroll		(1,110	)
Deferred tax liability		(1,422	)
Long-term operating lease liabilities		(1,615	)
Total purchase price	$	135,568

Alliance Home Health Care [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	17,062
Identifiable intangible assets		5,422
Cash		177
Accounts receivable		1,754
Accounts payable		(316	)
Other liabilities		(641	)
Total purchase price	$	23,458

VIP Health Care Services [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	11,936
Identifiable intangible assets		15,370
Cash		130
Accounts receivable		4,730
Operating lease assets, net		2,278
Other assets		30
Property and equipment		27
Accounts payable		(540	)
Accrued expenses		(770	)
Accrued payroll		(1,742	)
Long-term operating lease liabilities		(1,531	)
Total purchase price	$	29,918

Goodwill and Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2020

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Goodwill and Related Adjustments

A summary of the goodwill activity for the nine months ended September 30, 2020 is provided below:

	Goodwill
	Personal Care		Hospice			Home Health			Total
	(Amounts in Thousands)
Goodwill as of December 31, 2019	$	126,577	$	146,983		$	1,808		$	275,368
Additions for acquisition		11,252		—			—			11,252
Divestiture		—		(1,167	)		—			(1,167	)
Adjustments to previously recorded goodwill		1,438		(322	)		(17	)		1,099
Goodwill as of September 30, 2020	$	139,267	$	145,494		$	1,791		$	286,552

Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following as of September 30, 2020:

	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)
Intangible assets with indefinite lives		—			—			—			13,296			13,296
Intangible assets subject to amortization:
Gross carrying amount		48,028			31,946			4,655			12,164			96,793
Accumulated amortization		(37,263	)		(14,671	)		(2,716	)		(2,566	)		(57,216	)
Intangible assets subject to amortization, net		10,765			17,275			1,939			9,598			39,577
Total intangible assets at September 30, 2020	$	10,765		$	17,275		$	1,939		$	22,894		$	52,873

Details of Certain Balance Sheet Accounts (Tables)

9 Months Ended

Sep. 30, 2020

Details Of Certain Balance Sheet Accounts [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:

	September 30, 2020		December 31, 2019
	(Amounts in Thousands)
Income tax receivable	$	2,533	$	—
Workers’ compensation insurance receivable		2,186		1,989
Prepaid workers' compensation and liability insurance		1,792		2,040
Health insurance receivable		426		1,567
Other		3,489		2,397
Total prepaid expenses and other current assets	$	10,426	$	7,993

Schedule of Accrued Expenses

Accrued expenses consisted of the following:

	September 30, 2020		December 31, 2019
	(Amounts in Thousands)
Accrued payroll taxes ⁽¹⁾	$	8,448	$	1,843
Current portion of operating lease liabilities		8,057		7,234
Accrued health insurance		4,413		4,140
Accrued professional fees		3,135		2,517
Other		9,342		6,695
Total accrued expenses	$	33,395	$	22,429

(1)	The Company deferred $7.1 million of payroll taxes in connection to a provision included in the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), see Note 10 to the Notes to Consolidated Financial Statements for additional information.

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2020

Long Term Debt [Abstract]

Schedule of Long-Term Debt

Long-term debt consisted of the following:

	September 30, 2020			December 31, 2019
	(Amounts in Thousands)
Revolving loan under the credit facility	$	43,458		$	43,458
Term loan under the credit facility		18,375			18,865
Other debt		1,722			—
Financing leases		—			21
Less unamortized issuance costs		(1,899	)		(2,452	)
Total	$	61,656		$	59,892
Less current maturities		(2,095	)		(728	)
Long-term debt	$	59,561		$	59,164

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Segment Information (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Summary of Segment Information

	For the Three Months Ended September 30, 2020
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	165,916	$	23,986	$	4,085	$	193,987
Cost of services revenues		124,493		10,508		2,685		137,686
Gross profit		41,423		13,478		1,400		56,301
General and administrative expenses		14,837		5,904		925		21,666
Segment operating income	$	26,586	$	7,574	$	475	$	34,635

	For the Three Months Ended September 30, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	153,753	$	10,874	$	4,366	$	168,993
Cost of services revenues		115,504		5,495		2,818		123,817
Gross profit		38,249		5,379		1,548		45,176
General and administrative expenses		14,737		1,824		844		17,405
Segment operating income	$	23,512	$	3,555	$	704	$	27,771

	For the Three Months Ended September 30,
	2020			2019
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	34,635		$	27,771

Items not allocated at segment level:
Other general and administrative expenses		19,067			17,680
Depreciation and amortization		3,045			2,756
Interest income		(87	)		(786	)
Interest expense		680			866
Income before income taxes	$	11,930		$	7,255

	For the Nine Months Ended September 30, 2020
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	482,849	$	73,723	$	12,207	$	568,779
Cost of services revenues		359,344		33,749		8,553		401,646
Gross profit		123,505		39,974		3,654		167,133
General and administrative expenses		45,042		18,658		2,831		66,531
Segment operating income	$	78,463	$	21,316	$	823	$	100,602

	For the Nine Months Ended September 30, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	419,124	$	27,228	$	10,063	$	456,415
Cost of services revenues		314,329		13,587		6,803		334,719
Gross profit		104,795		13,641		3,260		121,696
General and administrative expenses		40,053		4,962		2,187		47,202
Segment operating income	$	64,742	$	8,679	$	1,073	$	74,494

	For the Nine Months Ended September 30,
	2020			2019
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	100,602		$	74,494

Items not allocated at segment level:
Other general and administrative expenses		58,939			46,907
Depreciation and amortization		8,872			7,365
Interest income		(576	)		(1,096	)
Interest expense		2,309			2,164
Income before income taxes	$	31,058		$	19,154

Significant Payors (Tables)

9 Months Ended

Sep. 30, 2020

Significant Payors [Abstract]

Schedule of Revenue by Payor Type

For the three and nine months ended September 30, 2020 and 2019, the Company’s revenue by payor type was as follows:

	Personal Care
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	85,344		51.5	%	$	75,176		48.9	%	$	242,751		50.3	%	$	221,450		52.8	%
Managed care organizations		71,700		43.2			68,438		44.5			213,087		44.1			170,004		40.6
Private pay		5,193		3.1			5,720		3.7			15,449		3.2			15,912		3.8
Commercial insurance		2,498		1.5			2,683		1.8			7,468		1.5			6,569		1.6
Other		1,181		0.7			1,736		1.1			4,094		0.9			5,189		1.2	%
Total personal care segment net service revenues	$	165,916		100.0	%	$	153,753		100.0	%	$	482,849		100.0	%	$	419,124		100.0

	Hospice
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	22,404		93.4	%	$	10,045		92.4	%	$	68,372		92.8	%	$	25,243		92.7	%
Managed care organizations		1,130		4.7			584		5.4			3,710		5.0			1,419		5.2
Other		452		1.9			245		2.2			1,641		2.2			566		2.1
Total hospice segment net service revenues	$	23,986		100.0	%	$	10,874		100.0	%	$	73,723		100.0	%	$	27,228		100.0	%

	Home Health
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	3,188		78.0	%	$	3,338		76.5	%	$	9,667		79.2	%	$	7,948		79.0	%
Managed care organizations		829		20.3			959		22.0			2,325		19.0			1,872		18.6
Other		68		1.7			69		1.5			215		1.8			243		2.4
Total home health segment net service revenues	$	4,085		100.0	%	$	4,366		100.0	%	$	12,207		100.0	%	$	10,063		100.0	%

Schedule of Revenue by Geographic Location

	Personal Care
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	74,448		44.9	%	$	61,633		40.1	%	$	215,047		44.6	%	$	178,449		42.5	%
New York		28,381		17.1			34,730		22.6			87,463		18.1			75,330		18.0
New Mexico		21,878		13.2			19,559		12.7			64,402		13.3			54,701		13.1
All other states		41,209		24.8			37,831		24.6			115,937		24.0			110,644		26.4
Total personal care segment net service revenues	$	165,916		100.0	%	$	153,753		100.0	%	$	482,849		100.0	%	$	419,124		100.0	%

	Hospice
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	10,979		45.8	%	$	10,874		100.0	%	$	33,431		45.3	%	$	27,228		100.0	%
All other states		13,007		54.2			—		—			40,292		54.7			—		—
Total hospice segment net service revenues	$	23,986		100.0	%	$	10,874		100.0	%	$	73,723		100.0	%	$	27,228		100.0	%

	Home Health
	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2020					2019					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	4,085		100.0	%	$	4,366		100.0	%	$	12,207		100.0	%	$	10,063		100.0	%
Total home health segment net service revenues	$	4,085		100.0	%	$	4,366		100.0	%	$	12,207		100.0	%	$	10,063		100.0	%

Nature of Operations, Consolidation, and Presentation of Financial Statements (Narrative) (Details)	9 Months Ended
	Sep. 30, 2020 segment
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Number of operating segments	3

Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]
Provision for doubtful accounts	$ 200		$ 681	$ 168
Allowance for doubtful accounts	$ 800		$ 800		$ 1,000
Accounting Standards Update 2016-13 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted	true		true
Change in accounting principle, accounting standards update, immaterial effect	true		true
Accounting Standards Update 2017-04 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted	true		true
Change in accounting principle, accounting standards update, immaterial effect	true		true
Accounting Standards Update 2018-15 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted	true		true
Change in accounting principle, accounting standards update, immaterial effect	true		true
Stock Options [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of potential diluted securities outstanding	523,000	650,000	523,000	650,000
Number of securities included in calculation of diluted earnings per share	301,000	359,000	303,000	335,000
Restricted Stock [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of potential diluted securities outstanding	149,000	147,000	149,000	147,000
Number of securities included in calculation of diluted earnings per share	38,000	78,000	58,000	81,000

Revision of Previously Issued Financial Statements (Consolidated Statements of Income) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues	$ 193,987	$ 168,993	$ 568,779	$ 456,415
Gross profit	56,301	45,176	167,133	121,696
General and administrative expenses	40,733	35,085	125,470	94,109
Total operating expenses	43,778	37,841	134,342	101,474
Operating income from continuing operations	12,523	7,335	32,791	20,222
Income from continuing operations before income taxes	11,930	7,255	31,058	19,154
Income tax expense	2,811	1,769	6,374	4,080
Net income from continuing operations	9,119	5,486	24,684	15,074
Net income	$ 9,119	$ 4,912	$ 24,684	$ 14,500
Basic income per share	$ 0.58	$ 0.36	$ 1.59	$ 1.10
Diluted income per share	$ 0.57	$ 0.35	$ 1.55	$ 1.06
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues		$ 169,803		$ 458,749
Gross profit		45,986		124,030
General and administrative expenses		35,950		95,429
Total operating expenses		38,706		102,794
Operating income from continuing operations		7,280		21,236
Income from continuing operations before income taxes		7,200		20,168
Income tax expense		1,759		4,347
Net income from continuing operations		5,441		15,821
Net income		$ 4,867		$ 15,247
Basic income per share		$ 0.36		$ 1.15
Diluted income per share		$ 0.34		$ 1.12
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues		$ (810)		$ (2,334)
Gross profit		(810)		(2,334)
General and administrative expenses		(865)		(1,320)
Total operating expenses		(865)		(1,320)
Operating income from continuing operations		55		(1,014)
Income from continuing operations before income taxes		55		(1,014)
Income tax expense		10		(267)
Net income from continuing operations		45		(747)
Net income		$ 45		$ (747)
Basic income per share				$ (0.05)
Diluted income per share		$ 0.01		$ (0.06)

Revision of Previously Issued Financial Statements (Consolidated Statement of Cash Flows) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income	$ 24,684	$ 14,500
Deferred income taxes	51	105
Accounts receivable	30,746	(19,957)
Accrued expenses and other long-term liabilities	7,570	(3,404)
Net cash provided by operating activities	$ 73,299	8,084
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income		15,247
Deferred income taxes		372
Accounts receivable		(22,291)
Accrued expenses and other long-term liabilities		(2,084)
Net cash provided by operating activities		8,084
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income		(747)
Deferred income taxes		(267)
Accounts receivable		2,334
Accrued expenses and other long-term liabilities		$ (1,320)

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

Leases (Narrative) (Details) $ in Millions	3 Months Ended	9 Months Ended
Leases (Narrative) (Details) $ in Millions	Sep. 30, 2020 USD ($) ft²	Sep. 30, 2020 USD ($) ft²
Lessee Lease [Line Items]
Operating lease expiration dates		expiration dates through 2031
Frisco Corporate Headquarter [Member]
Lessee Lease [Line Items]
Lease agreement term	11 years	11 years
Area of space before expand \| ft²	31,000	31,000
Area of space after expand \| ft²	75,000	75,000
Increase in the operating lease asset, net \| $	$ 17.3	$ 17.3
Increase in operating lease liability \| $	$ 22.2	$ 22.2
Minimum [Member]
Lessee Lease [Line Items]
Leases termination and renewal option		1 year
Maximum [Member]
Lessee Lease [Line Items]
Leases termination and renewal option		5 years

Leases (Amounts Reported in Unaudited Condensed Consolidated Balance Sheets for Operating Leases) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease assets, net	$ 35,842	$ 21,111
Short-term operating lease liabilities (in accrued expenses)	$ 8,057	$ 7,234
Operating lease, liability, current, statement of financial position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent	us-gaap:AccruedLiabilitiesCurrent
Long-term operating lease liabilities	$ 33,977	$ 14,301
Total operating lease liabilities	$ 42,034	$ 21,535

Leases (Components of Lease Cost Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Leases [Abstract]
Operating lease costs	$ 2,285	$ 1,897	$ 6,524	$ 5,101
Short-term lease costs	147	222	575	382
Total lease cost	$ 2,432	$ 2,119	$ 7,099	$ 5,483

Leases (Schedule of Weighted Average Remaining Lease Terms and Discount Rates) (Details)	Sep. 30, 2020	Dec. 31, 2019
Leases [Abstract]
Weighted average remaining lease term	7 years 2 months 26 days	3 years 5 months 1 day
Weighted average discount rate	4.33%	5.14%

Leases (Summary of Remaining Operating Lease Payments) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Leases [Abstract]
2021	$ 9,176
2022	8,704
2023	6,366
2024	4,704
2025	3,549
Thereafter	16,783
Total future minimum rental commitments	49,282
Less: Imputed interest	(7,248)
Total lease liabilities	$ 42,034	$ 21,535

Leases (Supplemental Cash Flows Information) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 6,472	$ 5,393
Right-of-use assets, net obtained in exchange for lease obligations:
Operating leases	$ 21,399	$ 5,536

Acquisitions (Narrative) (Details)					3 Months Ended		9 Months Ended
Acquisitions (Narrative) (Details)	Jul. 01, 2020 USD ($)	Oct. 01, 2019 USD ($) location $ / shares shares	Aug. 01, 2019 USD ($)	Jun. 01, 2019 USD ($)	Sep. 30, 2020 USD ($) $ / shares	Sep. 30, 2019 USD ($) shares	Sep. 30, 2020 USD ($) $ / shares	Sep. 30, 2019 USD ($) shares	Dec. 31, 2019 $ / shares
Business Acquisition [Line Items]
Total purchase price for business acquisition							$ 11,869,000	$ 53,224,000
Net service revenues					$ 193,987,000	$ 168,993,000	568,779,000	456,415,000
Operating income (loss) from continuing operations					$ 11,930,000	$ 7,255,000	$ 31,058,000	$ 19,154,000
Common stock, par value \| $ / shares					$ 0.001		$ 0.001		$ 0.001
Common Stock [Member]
Business Acquisition [Line Items]
Shares issued during period \| shares						2,300,000		2,300,000
Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives							25 years
Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives							3 years
Trade Names [Member]
Business Acquisition [Line Items]
Identifiable intangible assets acquired								$ 1,400
Customer Relationships [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives							10 years
Customer Relationships [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives							5 years
A Plus Health Care, Inc [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition	$ 12,200,000
Excess cash held by acquired business	$ 2,800,000
Acquisition related costs					$ 300,000		$ 300,000
Net service revenues					2,600,000		2,600,000
Operating income (loss) from continuing operations					500,000		500,000
A Plus Health Care, Inc [Member] \| Trade Names [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives	15 years
Identifiable intangible assets acquired	$ 1,400,000
Hospice Partners [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition		$ 135,600,000
Net service revenues					13,000,000.0		40,300,000
Operating income (loss) from continuing operations					3,500,000		9,500,000
Number of locations \| location		21
Integration costs							1,500,000
Hospice Partners [Member] \| Common Stock [Member]
Business Acquisition [Line Items]
Shares issued during period \| shares		2,300,000
Common stock, par value \| $ / shares		$ 0.001
Public offering price, per share \| $ / shares		$ 79.50
Hospice Partners [Member] \| Common Stock [Member] \| Over Allotment Option [Member]
Business Acquisition [Line Items]
Shares issued during period \| shares		300,000
Hospice Partners [Member] \| Trade Names [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives		15 years
Identifiable intangible assets acquired		$ 9,500,000
Hospice Partners [Member] \| Noncompete Agreements
Business Acquisition [Line Items]
Identifiable intangible assets acquired		$ 2,500,000
Hospice Partners [Member] \| Noncompete Agreements \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives		5 years
Hospice Partners [Member] \| Noncompete Agreements \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives		3 years
Hospice Partners [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Indefinite lived intangible assets acquired		$ 6,100,000
Alliance Home Health Care [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition			$ 23,500,000
Integration costs						$ 300,000	200,000	300,000
Alliance Home Health Care [Member] \| New York [Member]
Business Acquisition [Line Items]
Net service revenues					3,300,000	3,400,000	12,000,000.0	3,400,000
Operating income (loss) from continuing operations					700,000	800,000	2,700,000	800,000
Alliance Home Health Care [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives			10 years
Identifiable intangible assets acquired			$ 1,100,000
Indefinite lived intangible assets acquired			$ 4,300,000
VIP Health Care Services [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition				$ 29,900,000
Acquisition related costs								300,000
Integration costs						200,000	200,000	300,000
VIP Health Care Services [Member] \| New York [Member]
Business Acquisition [Line Items]
Net service revenues					9,700,000	13,200,000	30,500,000	17,600,000
Operating income (loss) from continuing operations					$ (400,000)	$ (400,000)	$ (1,100,000)	$ (100,000)
VIP Health Care Services [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives				6 years
Identifiable intangible assets acquired				$ 10,700,000
VIP Health Care Services [Member] \| Customer Relationships [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives				8 years
Identifiable intangible assets acquired				$ 4,700,000

Acquisitions (Schedule of Fair Values of Assets and Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jul. 01, 2020	Dec. 31, 2019	Oct. 01, 2019	Aug. 01, 2019	Jun. 01, 2019
Business Acquisition [Line Items]
Goodwill	$ 286,552		$ 275,368
A Plus Health Care, Inc [Member]
Business Acquisition [Line Items]
Goodwill		$ 11,252
Identifiable intangible assets		1,523
Cash		2,819
Accounts receivable		1,075
Operating lease assets, net		180
Other assets		23
Accounts payable		(18)
Accrued expenses		(202)
Accrued payroll		(303)
Current portion of long-term debt		(577)
Long-term debt		(1,145)
Long-term operating lease liabilities		(100)
Total purchase price		$ 14,527
Hospice Partners [Member]
Business Acquisition [Line Items]
Goodwill				$ 111,674
Identifiable intangible assets				18,090
Cash				5,489
Property and equipment				164
Accounts receivable				6,411
Operating lease assets, net				2,425
Other assets				702
Accounts payable				(1,737)
Accrued expenses				(3,503)
Accrued payroll				(1,110)
Deferred tax liability				(1,422)
Long-term operating lease liabilities				(1,615)
Total purchase price				$ 135,568
Alliance Home Health Care [Member]
Business Acquisition [Line Items]
Goodwill					$ 17,062
Identifiable intangible assets					5,422
Cash					177
Accounts receivable					1,754
Accounts payable					(316)
Other liabilities					(641)
Total purchase price					$ 23,458
VIP Health Care Services [Member]
Business Acquisition [Line Items]
Goodwill						$ 11,936
Identifiable intangible assets						15,370
Cash						130
Property and equipment						27
Accounts receivable						4,730
Operating lease assets, net						2,278
Other assets						30
Accounts payable						(540)
Accrued expenses						(770)
Accrued payroll						(1,742)
Long-term operating lease liabilities						(1,531)
Total purchase price						$ 29,918

Acquisitions (Unaudited Pro Forma Condensed Consolidated Income Statement Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Business Acquisition Pro Forma Information [Abstract]
Net service revenues	$ 193,987	$ 187,846	$ 573,917	$ 541,646
Operating income from continuing operations	12,269	9,291	32,136	26,328
Net income from continuing operations	$ 9,458	$ 6,922	$ 25,663	$ 20,518
Basic income per share	$ 0.61	$ 0.50	$ 1.65	$ 1.55

Goodwill and Intangible Assets (Summary of Goodwill and Related Adjustments) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
Goodwill [Line Items]
Goodwill, at Beginning of Period	$ 275,368
Additions for acquisition	11,252
Divestiture	(1,167)
Adjustments to previously recorded goodwill	1,099
Goodwill, at End of Period	286,552
Personal Care [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	126,577
Additions for acquisition	11,252
Adjustments to previously recorded goodwill	1,438
Goodwill, at End of Period	139,267
Hospice [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	146,983
Divestiture	(1,167)
Adjustments to previously recorded goodwill	(322)
Goodwill, at End of Period	145,494
Home Health [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	1,808
Adjustments to previously recorded goodwill	(17)
Goodwill, at End of Period	$ 1,791

Goodwill and Intangible Assets (Narrative) (Details) - USD ($)		3 Months Ended		9 Months Ended
	Jul. 01, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Goodwill [Line Items]
Goodwill		$ 286,552,000		$ 286,552,000		$ 275,368,000
Adjustment of goodwill related to divestiture				1,167,000
Amortization expense		1,700,000	$ 1,800,000	$ 5,300,000	$ 4,400,000
Weighted average remaining lives of identifiable intangible assets				8 years 8 months 12 days
Personal Care [Member]
Goodwill [Line Items]
Goodwill		139,267,000		$ 139,267,000		$ 126,577,000
A Plus Health Care, Inc [Member]
Goodwill [Line Items]
Goodwill	$ 11,252,000
A Plus Health Care, Inc [Member] \| Personal Care [Member]
Goodwill [Line Items]
Goodwill		11,300,000		11,300,000
General and Administrative Expense [Member]
Goodwill [Line Items]
Loss of disposal of assets		$ 300,000		$ 300,000
Trade Names [Member]
Goodwill [Line Items]
Identifiable intangible assets acquired					$ 1,400
Trade Names [Member] \| A Plus Health Care, Inc [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives	15 years
Identifiable intangible assets acquired	$ 1,400,000
Minimum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				3 years
Minimum [Member] \| Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				5 years
Maximum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				25 years
Maximum [Member] \| Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				10 years

Goodwill and Intangible Assets (Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Finite Lived Intangible Assets [Line Items]
Intangible assets with indefinite lives	$ 13,296
Intangible assets subject to amortization:
Gross carrying amount	96,793
Accumulated amortization	(57,216)
Intangible assets subject to amortization, net	39,577
Total intangible assets at September 30, 2020	52,873	$ 57,079
Customer and Referral Relationships [Member]
Intangible assets subject to amortization:
Gross carrying amount	48,028
Accumulated amortization	(37,263)
Intangible assets subject to amortization, net	10,765
Total intangible assets at September 30, 2020	10,765
Trade Names And Trademarks [Member]
Intangible assets subject to amortization:
Gross carrying amount	31,946
Accumulated amortization	(14,671)
Intangible assets subject to amortization, net	17,275
Total intangible assets at September 30, 2020	17,275
Noncompete Agreements
Intangible assets subject to amortization:
Gross carrying amount	4,655
Accumulated amortization	(2,716)
Intangible assets subject to amortization, net	1,939
Total intangible assets at September 30, 2020	1,939
State Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets with indefinite lives	13,296
Intangible assets subject to amortization:
Gross carrying amount	12,164
Accumulated amortization	(2,566)
Intangible assets subject to amortization, net	9,598
Total intangible assets at September 30, 2020	$ 22,894

Details of Certain Balance Sheet Accounts (Schedule of Prepaid Expenses and Other Current Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Details Of Certain Balance Sheet Accounts [Abstract]
Income tax receivable	$ 2,533
Workers’ compensation insurance receivable	2,186	$ 1,989
Prepaid workers' compensation and liability insurance	1,792	2,040
Health insurance receivable	426	1,567
Other	3,489	2,397
Total prepaid expenses and other current assets	$ 10,426	$ 7,993

Details of Certain Balance Sheet Accounts (Schedule of Accrued Expenses) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Details Of Certain Balance Sheet Accounts [Abstract]
Accrued payroll taxes	$ 8,448	$ 1,843
Current portion of operating lease liabilities	8,057	7,234
Accrued health insurance	4,413	4,140
Accrued professional fees	3,135	2,517
Other	9,342	6,695
Total accrued expenses	$ 33,395	$ 22,429

Details of Certain Balance Sheet Accounts (Schedule of Accrued Expenses) (Parenthetical) (Details) $ in Millions	Sep. 30, 2020 USD ($)
CARES Act [Member]
Schedule Of Accrued Expenses [Line Items]
Deferred payroll taxes	$ 7.1

Long-Term Debt (Schedule of Long-Term Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Other debt	$ 1,722
Financing leases		$ 21
Less unamortized issuance costs	(1,899)	(2,452)
Total	61,656	59,892
Less current maturities	(2,095)	(728)
Long-term debt	59,561	59,164
Revolving Credit Loan [Member] \| Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	43,458	43,458
Term Loan [Member] \| Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	$ 18,375	$ 18,865

Long-Term Debt (Narrative) (Details) - USD ($)			9 Months Ended
Long-Term Debt (Narrative) (Details) - USD ($)	Sep. 12, 2019	Oct. 31, 2018	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt issuance costs			$ 1,899,000	$ 2,452,000
Credit Agreement [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		$ 269,600,000	219,000,000.0	191,400,000
Debt instrument, maturity date		May 08, 2023
Debt instrument total net leverage ratio		4.25%
Debt issuance costs		$ 900,000
Line of credit outstanding amount			9,300,000	10,000,000.0
Credit Agreement [Member] \| Capital One, National Association [Member] \| Delayed Draw Term Loan [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		$ 19,600,000
Credit Agreement [Member] \| Capital One, National Association [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Line of credit outstanding amount			$ 18,400,000	$ 18,900,000
Debt instrument stated interest rate			1.89%	3.45%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument total net leverage ratio		3.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		0.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		1.00%
Credit Agreement [Member] \| Capital One, National Association [Member] \| London Interbank Offered Rate (LIBOR) \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		0.00%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		0.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		1.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		1.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		2.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Restriction on Dividends [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Aggregate amount of dividends and distributions	$ 7,500,000
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available	300,000,000.0	$ 250,000,000.0
Increase in credit facility	50,000,000.0
Debt issuance costs	$ 400,000
Proceeds from line of credit			$ 0
Line of credit outstanding amount			$ 43,400,000	$ 43,400,000
Debt instrument stated interest rate			1.89%	3.44%
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility	0.20%
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility	0.35%

Income Taxes (Narrative) (Details)	3 Months Ended		9 Months Ended
Income Taxes (Narrative) (Details)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Effective income tax rate	23.60%	24.40%	20.50%	21.30%

Commitments and Contingencies (Narrative) (Details) - PPPHCE Act [Member] - USD ($) $ in Millions		1 Months Ended
	Apr. 24, 2020	Apr. 30, 2020	Sep. 30, 2020
Commitment And Contingencies [Line Items]
Authorized fund to be distributed to health care providers	$ 175,000.0
Aggregate principal amount of grants received		$ 6.9
Deferred payroll taxes period		2 years
Deferred payroll taxes			$ 7.1

Segment Information (Narrative) (Details)	9 Months Ended
Segment Information (Narrative) (Details)	Sep. 30, 2020 segment
Segment Reporting [Abstract]
Number of business segments	3

Segment Information (Summary Of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Net service revenues	$ 193,987	$ 168,993	$ 568,779	$ 456,415
Cost of services revenues	137,686	123,817	401,646	334,719
Gross profit	56,301	45,176	167,133	121,696
General and administrative expenses	40,733	35,085	125,470	94,109
Operating income from continuing operations	12,523	7,335	32,791	20,222
Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	21,666	17,405	66,531	47,202
Operating income from continuing operations	34,635	27,771	100,602	74,494
Personal Care [Member]
Segment Reporting Information [Line Items]
Net service revenues	165,916	153,753	482,849	419,124
Cost of services revenues	124,493	115,504	359,344	314,329
Gross profit	41,423	38,249	123,505	104,795
Personal Care [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	14,837	14,737	45,042	40,053
Operating income from continuing operations	26,586	23,512	78,463	64,742
Hospice [Member]
Segment Reporting Information [Line Items]
Net service revenues	23,986	10,874	73,723	27,228
Cost of services revenues	10,508	5,495	33,749	13,587
Gross profit	13,478	5,379	39,974	13,641
Hospice [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	5,904	1,824	18,658	4,962
Operating income from continuing operations	7,574	3,555	21,316	8,679
Home Health [Member]
Segment Reporting Information [Line Items]
Net service revenues	4,085	4,366	12,207	10,063
Cost of services revenues	2,685	2,818	8,553	6,803
Gross profit	1,400	1,548	3,654	3,260
Home Health [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	925	844	2,831	2,187
Operating income from continuing operations	$ 475	$ 704	$ 823	$ 1,073

Segment Information (Segment Reconciliation to Totals reported in the accompanying Consolidated Financial Statements) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Operating income from continuing operations	$ 12,523	$ 7,335	$ 32,791	$ 20,222
Other general and administrative expenses	19,067	17,680	58,939	46,907
Depreciation and amortization	3,045	2,756	8,872	7,365
Interest income	(87)	(786)	(576)	(1,096)
Interest expense	680	866	2,309	2,164
Income from continuing operations before income taxes	11,930	7,255	31,058	19,154
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income from continuing operations	$ 34,635	$ 27,771	$ 100,602	$ 74,494

Significant Payors (Revenue by Payor Type) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net service revenues	$ 193,987	$ 168,993	$ 568,779	$ 456,415
Personal Care [Member]
Net service revenues	165,916	153,753	482,849	419,124
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 165,916	$ 153,753	$ 482,849	$ 419,124
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| State, Local And Other Governmental Programs [Member]
Net service revenues	$ 85,344	$ 75,176	$ 242,751	$ 221,450
Concentration risk, percentage	51.50%	48.90%	50.30%	52.80%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 71,700	$ 68,438	$ 213,087	$ 170,004
Concentration risk, percentage	43.20%	44.50%	44.10%	40.60%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Private Pay [Member]
Net service revenues	$ 5,193	$ 5,720	$ 15,449	$ 15,912
Concentration risk, percentage	3.10%	3.70%	3.20%	3.80%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Commercial Insurance [Member]
Net service revenues	$ 2,498	$ 2,683	$ 7,468	$ 6,569
Concentration risk, percentage	1.50%	1.80%	1.50%	1.60%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 1,181	$ 1,736	$ 4,094	$ 5,189
Concentration risk, percentage	0.70%	1.10%	0.90%	1.20%
Hospice [Member]
Net service revenues	$ 23,986	$ 10,874	$ 73,723	$ 27,228
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 23,986	$ 10,874	$ 73,723	$ 27,228
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues	$ 22,404	$ 10,045	$ 68,372	$ 25,243
Concentration risk, percentage	93.40%	92.40%	92.80%	92.70%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 1,130	$ 584	$ 3,710	$ 1,419
Concentration risk, percentage	4.70%	5.40%	5.00%	5.20%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 452	$ 245	$ 1,641	$ 566
Concentration risk, percentage	1.90%	2.20%	2.20%	2.10%
Home Health [Member]
Net service revenues	$ 4,085	$ 4,366	$ 12,207	$ 10,063
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 4,085	$ 4,366	$ 12,207	$ 10,063
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues	$ 3,188	$ 3,338	$ 9,667	$ 7,948
Concentration risk, percentage	78.00%	76.50%	79.20%	79.00%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 829	$ 959	$ 2,325	$ 1,872
Concentration risk, percentage	20.30%	22.00%	19.00%	18.60%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 68	$ 69	$ 215	$ 243
Concentration risk, percentage	1.70%	1.50%	1.80%	2.40%

Significant Payors (Revenue by Geographic Location) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net service revenues	$ 193,987	$ 168,993	$ 568,779	$ 456,415
Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Concentration risk, percentage	38.50%	36.40%	37.80%	39.10%
Personal Care [Member]
Net service revenues	$ 165,916	$ 153,753	$ 482,849	$ 419,124
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 165,916	$ 153,753	$ 482,849	$ 419,124
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Net service revenues	$ 74,448	$ 61,633	$ 215,047	$ 178,449
Concentration risk, percentage	44.90%	40.10%	44.60%	42.50%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New York [Member]
Net service revenues	$ 28,381	$ 34,730	$ 87,463	$ 75,330
Concentration risk, percentage	17.10%	22.60%	18.10%	18.00%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 21,878	$ 19,559	$ 64,402	$ 54,701
Concentration risk, percentage	13.20%	12.70%	13.30%	13.10%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues	$ 41,209	$ 37,831	$ 115,937	$ 110,644
Concentration risk, percentage	24.80%	24.60%	24.00%	26.40%
Hospice [Member]
Net service revenues	$ 23,986	$ 10,874	$ 73,723	$ 27,228
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 23,986	$ 10,874	$ 73,723	$ 27,228
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 10,979	$ 10,874	$ 33,431	$ 27,228
Concentration risk, percentage	45.80%	100.00%	45.30%	100.00%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues	$ 13,007		$ 40,292
Concentration risk, percentage	54.20%		54.70%
Home Health [Member]
Net service revenues	$ 4,085	$ 4,366	$ 12,207	$ 10,063
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 4,085	$ 4,366	$ 12,207	$ 10,063
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 4,085	$ 4,366	$ 12,207	$ 10,063
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%

Significant Payors (Narrative) (Details)	3 Months Ended		9 Months Ended		12 Months Ended
Significant Payors (Narrative) (Details)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Revenues [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	22.90%	22.10%	23.10%	26.00%
Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.50%	36.40%	37.80%	39.10%
Accounts Receivable [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			18.50%		25.10%

Subsequent Events (Narrative) (Details) - USD ($) $ in Thousands		9 Months Ended
	Nov. 01, 2020	Sep. 30, 2020	Sep. 30, 2019
Subsequent Event [Line Items]
Total purchase price for business acquisition		$ 11,869	$ 53,224
Subsequent Event [Member] \| County HomeMakers, Inc. [Member]
Subsequent Event [Line Items]
Total purchase price for business acquisition	$ 14,600